The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
GlobeNewswire public company news · 2026-10-08 18:16
証拠を見る
- 企業開示GlobeNewswire public company news2026-10-08 18:16
The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
出典を見る